Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cancer Immunology, Immunotherapy
Published in: Cancer Immunology, Immunotherapy 9/2001

01-11-2001 | Original Article

Dendritic cells pulsed with tumor extract–cationic liposome complex increase the induction of cytotoxic T lymphocytes in mouse brain tumor

Authors: Hideo Aoki, Masaaki Mizuno, Atsushi Natsume, Takahiko Tsugawa, Kunio Tsujimura, Toshitada Takahashi, Jun Yoshida

Published in: Cancer Immunology, Immunotherapy | Issue 9/2001

Login to get access
Metadata
Title
Dendritic cells pulsed with tumor extract–cationic liposome complex increase the induction of cytotoxic T lymphocytes in mouse brain tumor
Authors
Hideo Aoki
Masaaki Mizuno
Atsushi Natsume
Takahiko Tsugawa
Kunio Tsujimura
Toshitada Takahashi
Jun Yoshida
Publication date
01-11-2001
Publisher
Springer-Verlag
Published in
Cancer Immunology, Immunotherapy / Issue 9/2001
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI
https://doi.org/10.1007/s002620100220

Other articles of this Issue 9/2001

Cancer Immunology, Immunotherapy 9/2001 Go to the issue

Original Article

Biodistribution of 111indium-labeled macrophages infused intravenously in patients with renal carcinoma

Original Article

Nitric oxide synthase inhibitor and IL-18 enhance the anti-tumor immune response of rats carrying an intrahepatic colon carcinoma

Original Article

A TGFβRII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8+ T cells

Original Article

Purified hybrid cells from dendritic cell and tumor cell fusions are superior activators of antitumor immunity

Original Article

Soluble ICAM-1 in breast cancer: clinical significance and biological implications

Original Article

Treatment of human colon carcinoma cell lines with anti-neoplastic agents enhances their lytic sensitivity to antigen-specific CD8+ cytotoxic T lymphocytes
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits